Pursuant to the terms of the BCA, (i) Jeffery R. Bray tendered 378,593 shares of UHI Stock in
exchange for 4,088,170 shares of Common Stock; (ii) Alexandra Bray tendered 44,035 shares of UHI Stock in exchange for 475,504 shares of Common Stock; (iii) Samantha Josephine Bray UTMA tendered 44,035 shares of UHI Stock in exchange for
475,504 shares of Common Stock; (iv) Anais Alexandra Bray UTMA tendered 44,035 shares of UHI Stock in exchange for 475,504 shares of Common Stock; (v) A. Bray Trust tendered 250,000 shares of UHI Stock in exchange for 2,699,582 shares of
Common Stock; (vi) S. Bray Trust tendered 250,000 shares of UHI Stock in exchange for 2,699,582 shares of Common Stock; (vii) Bray Descendants Trust tendered 100,000 shares of UHI Stock in exchange for 1,079,833 shares of Common Stock;
(vii) Jacque Butler tendered 130,002 shares of UHI Stock in exchange for 1,403,804 shares of Common Stock; (viii) Alfonso Gatmaitan tendered 100,000 shares of UHI Stock in exchange for 1,079,833 shares of Common Stock; (ix) AM
Physicians LLC tendered 89,130 shares of UHI Stock in exchange for 962,458 shares of Common Stock; (x) Dr. Kathuria tendered 3,991,400 shares of UHI Stock in exchange for 43,100,443 shares of Common Stock; (xi) Dr. Pylypiv
tendered 691,000 shares of UHI Stock in exchange for 7,461,644 shares of Common Stock; (xii) Dr. Azim tendered 251.530 shares of UHI Stock in exchange for 2,716,319 shares of Common Stock, (xiii) Ms. Azim tendered 251,478 shares
of UHI Stock in exchange for 2,715,542 shares of Common Stock; and (xiv) Kimberlite tendered 63,434 shares of UHI Stock in exchange for 684,981 shares of Common Stock.
The aggregate amount beneficially owned by Dr. Malik does not include 193,541 shares of Common Stock owned by his sister-in-law, who shares a home with Dr.
Malik, for which he disclaims beneficial ownership.
Dr. Kathuria acquired 58,309 shares of Common Stock upon the vesting of restricted stock
units previously granted to Dr. Kathuria, including 40,376 shares that vested on May 1, 2022, without the payment by Dr. Kathuria of other funds or similar consideration. Dr. Pylypiv acquired (i) 30,000 shares via purchase on or
about November 17, 2022 and (ii) 51,813 shares of Common Stock upon the vesting of restricted stock units previously granted to Dr. Pylypiv which vested on May 1, 2022, without the payment of other funds or similar considerations. The
aggregate amount beneficially owned by Dr. Pylypiv does not include 43,000 shares of Common Stock owned by her spouse for which she disclaims beneficial ownership.
Alfonso Gatmaitan acquired 103,527 shares of Common Stock upon the vesting of restricted stock units previously granted to Mr. Gatmaitan, which vested on
January 28, 2022, without payment by Mr. Gatmaitan of other funds or similar consideration.
In connection with the closing of the Cloudbreak
Healthcare, LLC (Cloudbreak) business combination (the Cloudbreak Closing), (i) GigCapital2 agreed to repay or cause to be repaid on behalf of Cloudbreak certain debt obligations of Cloudbreak and
(ii) Dr. Kathuria, and Dr. Pylypiv have agreed to subject 4,688,365 and 811,635 of their shares of Common Stock, respectively, to potential forfeiture and transfer (such transfer, the Business Combination Share
Adjustment) to the former members of Cloudbreak (the Members) in connection with a Valuation Shortfall (as defined below) on the 540th day from the Closing Date (or if such day is not a business day, the following
business day) (the Measurement Date) as provided in the Cloudbreak Business Combination Agreement. A Valuation Shortfall shall occur if the dollar volume-weighted average price for the Common Stock on the New York Stock Exchange
during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time, as reported by Bloomberg through its HP function (set to weighted average) or if not available on Bloomberg, as reported by Morningstar (the
VWAP) for the ten trading days preceding the Measurement Date (the Reference VWAP) is less than $13.64, and the amount of such Valuation Shortfall is the difference between $13.64 and the Reference VWAP. In the
event that a Valuation Shortfall occurs, the amount of shares of Common Stock that Dr. Kathuria and Dr. Pylypiv shall forfeit to the Members will be the lesser of (i) the Adjustment Amount and (ii) 5,500,000 (or, if the Adjustment
Amount equals 5,500,000, the Adjustment Amount). The Adjustment Amount means the quotient (rounded up to the nearest whole number) of (A) the Aggregate Valuation Shortfall, divided by (B) the Reference VWAP. The Aggregate Valuation
Shortfall means the product of (A) the amount of the Valuation Shortfall, multiplied by (B) 11,000,000.
Dr. Kathuria, Dr. Pylypiv and
Mr. Gatmaitan have pledged approximately 834,608, 144,490, and 20,902 shares of Common Stock, respectively, to the Company to secure any obligation they may have to the Company required to be paid by the Company to a third party advisory firm
in connection with disputed amounts the advisory firm claims are owed to it by the Company.